Direct answer: SmileDirectClub's bankruptcy resulted from a combination of regulatory headwinds, organized dental profession opposition, and a business model that required continuous customer acquisition spending to maintain revenue. State dental boards pursued regulatory actions claiming SmileDirectClub's remote treatment model constituted practicing dentistry without required oversight. Negative social media reviews of outcomes accumulated. Orthodontic associations lobbied against the company. Marketing costs required to acquire customers grew while customer satisfaction declined. The company could not achieve profitability at any scale before running out of capital.
SmileDirectClub Investment Autopsy: What Actually Went Wrong?
The investment
Category: DTC Healthcare / Cash Burn
Era: 2019-2023
Primary failure mechanism: regulatory challenge / dental profession opposition / cash depletion
What investors believed
SmileDirectClub would disrupt orthodontics by offering clear aligners at roughly one-third the cost of traditional orthodontic treatment through a direct-to-consumer model eliminating the orthodontist markup.
What broke
Regulatory and professional opposition limited the addressable market. Treatment outcomes for complex cases were worse without in-person supervision. Negative reviews compounded customer acquisition costs. The capital-intensive direct-to-consumer model required sustained profitability that never arrived.
Warning signals that were visible
- State dental board regulatory actions beginning before IPO
- Negative treatment outcome reviews visible on consumer platforms
- IPO valuation pricing in growth that required market expansion the dental profession was actively blocking
- Customer acquisition costs increasing as organic word-of-mouth turned negative
Transferable lessons
- Healthcare disruption faces professional licensing and regulatory opposition that pure technology disruption does not
- DTC models require positive word-of-mouth to sustain customer acquisition economics
- Treatment outcomes that vary by case complexity matter more in healthcare than in retail
- Regulatory risk in a licensed profession is a structural business risk not reducible by lobbying
Frequently Asked Questions
What was SmileDirectClub's regulatory challenge?
Multiple state dental boards issued cease and desist orders or pursued regulatory actions against SmileDirectClub, asserting that its remote assessment and treatment model constituted practicing dentistry or orthodontics without required professional supervision. Dental practice acts in most states require in-person examination before prescribing orthodontic treatment. SmileDirectClub used teledentistry and photo assessments to screen customers and argued this was legally compliant. Courts and regulators reached different conclusions in different states, creating a patchwork of operating constraints that limited the company's addressable market.
What happened to customers mid-treatment when SmileDirectClub went bankrupt?
When SmileDirectClub filed for Chapter 11 bankruptcy in September 2023 and subsequently converted to Chapter 7 liquidation, thousands of customers were mid-treatment with aligners ordered but not yet completed. The company initially attempted to maintain treatment capabilities during bankruptcy but the liquidation ended ongoing services. Customers had limited recourse: prepaid treatment plans represented unsecured creditor claims with low expected recovery. The situation highlighted the risks of prepaying for long-duration healthcare treatment from a startup company.
How did SmileDirectClub compare to Invisalign in business model?
Align Technology's Invisalign product is dispensed through licensed orthodontists and dentists, not directly to consumers. Align benefits from professional endorsement and in-person treatment monitoring. SmileDirectClub's model treated the orthodontist as a cost to eliminate rather than a professional whose judgment added value. The comparison suggests that professional channel distribution in healthcare provides both regulatory legitimacy and outcome quality assurance that direct-to-consumer substitution cannot fully replicate.